TAKEDA PHARMACEUTICAL CO LTD NPV earnings per share and revenue

0RN3 earnings per share for the last quarter are 0.36 EUR whereas the estimation was 0.23 EUR which accounts for 57.13% surprise. Company revenue for the same period amounts to 7.35 B EUR despite the estimated figure of 6.80 B EUR. Estimated earnings per share for the next quarter are 0.20 EUR, and revenue is expected to reach 7.09 B EUR. Also watch annual changes over time to get a bigger picture of 0RN3 earnings per share and revenue dynamics.